Detecting in-school transmission of SARS-CoV-2 from case ratios and documented clusters

Competing Interest Statement

M.S. and A.C. are shareholders in Fractal Therapeutics. This does not alter our adherence to policies on sharing data and materials. Fractal Therapeutics intends to purse the development of prophylactics and therapeutics for SARS-CoV-2, but has no other business or financial interest in the topic of this paper. The remaining authors have declared no competing interest.

Funding Statement

We acknowledge the financial support from NIH Grant R01 AI151176 and CDC Grant U01IP001136. M.S. received funding from Fractal Therapeutics for the duration of this project. The funding organization did not play a role in the study design, data analysis, decision to publish or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NA

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes